Clinical Trials at TMH
A clinical trials program is an essential part of a true cancer center. All of the current treatments for oncology patients today have been developed from yesterday’s trials. Our program enables patients in our community to receive potential direct benefit of new drugs and treatment pathways while sleeping in their own bed at night, but also indirectly builds the science for future patients who may be their loved ones.
Breast Cancer Trials
NRG-BR003: For newly diagnosed patients with Triple Negative Breast Cancer, looking at the addition of Carboplatin to the current standard treatment, to see if it will keep the cancer from growing or coming back as quickly. Learn More.
S1418/BR006: For patients diagnosed with Triple Negative Breast Cancer who have received neoadjuvant treatment (chemotherapy before surgery), and whose cancer has at least partly survived that treatment. This study is being done to see the effect of Pembrolizumab, a type of immunotherapy, in treating patients with this diagnosis. Learn More.
POL6326-009: This trial is looking at the combination of Balixafortide and Eribulin vs Eribulin alone, in patients with HER 2 negative, locally recurrent or metastatic breast cancer. Patients must have already received 1 line of therapy, and no more than 5 lines of therapy. Learn More.
I3Y-MC-JPCU: A trial using Abemaciclib in combination with Fulvestrant, compared to chemotherapy, in women with hormone positive, HER 2 negative metastatic breast cancer. Learn More.
A011401/BWEL: A study that will evaluate the benefit of weight loss and the recurrence of breast cancer, after surgery and routine postoperative therapy, in overweight women with early stage HER 2 negative breast cancer. Learn More.
We are now a participant in the nationwide Cancer Experience Registry. This is an online initiative to understand the experiences of those impacted by a cancer diagnosis. The Cancer Experience Registry is open to anyone who has been diagnosed with cancer—as well as those relatives or friends who assist with their care. The information from the Cancer Experience Registry helps us identify the issues that are more important to you and use that information to fill the gaps in care and deliver improved services to the cancer community. People impacted by cancer—patients and caregivers—are experts in their needs and experiences. The Cancer Experience Registry puts the patient experience and patient voice at the center of the cancer conversation. Register for this study.